摘要
糖尿病(DM)合并高血压患病率在中老年人群中呈上升趋势,且家族性患病率偏高,DM与高血压有共同发病基础是胰岛素抵抗(IR),DM与高血压并存加速了各靶器官的损害,重视此类患者血压与重视血糖同样重要,强调积极控制血压比控制血糖对DM患者预后更有益处,可明显降低大血管、微血管事件的发生和病死率,基层医院医生过多顾及β受体阻滞剂的不良反应,使β受体阻滞剂在DM合并高血压治疗中使用受限,本文强调选择性β1受体阻滞剂在DM合并高血压患者治疗中的重要性和安全性,可降低DM患者总病死率,改善预后。
The morbidity of hypertension in combination with diabetes mellites is upgrading in middle-nged and aged people, and its familial is leaning higher. Insulin resistance （IR） is the same basis of DM and hypertension. Concomitance of DM and hypertension accelerates the damage of target organs, so it has an equal importance to pay attention to the blood pressure and blood sugar level of this kind of patients. As for the prognosis of DM, it is more useful to control the blood pressure actively than blood sugar, which can decrease the occurrence of great vessels and capillary cases and mortality obviously. Doctors in region hospital considered adverse effect of β-adrenergie blocker so excessively that β-adrenergic blocker was limited in the therapy of DM in combination with hypertension. The article emphasized the importance and security of selective β1-adrenergic blocker in the therapy of DM in combination with hypertension, and its effect in cutting down general death rate and improving the prognesis of this kind of patients.
出处
《医学综述》
2006年第8期476-477,共2页
Medical Recapitulate
关键词
Β受体阻滞剂
糖尿病
高血压
β-adrenergic blocker
Diabetes mellitus
Hypertension
